Predictors of the efficacy of FOLFIRI plus bevacizumab as second-line treatment in metastatic colorectal cancer patients
Mitsukuni Suenaga, Satoshi Matsusaka, Masashi Ueno, Noriko Yamamoto, Eiji Shinozaki, Nobuyuki Mizunuma, Toshiharu Yamaguchi, Kiyohiko HatakeVolume:
41
Language:
english
Pages:
8
DOI:
10.1007/s00595-010-4432-8
Date:
August, 2011
File:
PDF, 148 KB
english, 2011